Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01134159 · ClinicalTrials.gov registry record
Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V
A clinical trial, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- 1,200
- Enrollment target
NCT01134159: Completed study, sponsored by Medstar Health Research Institute.
NCT01134159 is a clinical trial that has completed, run by Medstar Health Research Institute. The registered enrollment target is 1,200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01134159 has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- 1,200 participants
- Enrollment target
Study Summary
Multicenter, retrospective registry to collect 9-12 month follow-up data to evaluate major adverse cardiac events in patients whom have undergone percutaneous coronary intervention and received either Taxus Liberte or Xience V.
Primary Outcome
A composite of all-cause death, Q-wave myocardial infarction, and target vessel revascularization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2010-06 |
| Est. Completion | 2010-09 |
What the finished NCT01134159 record still lists
NCT01134159 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01134159 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01134159 about?
NCT01134159 is a clinical study titled "Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V". Multicenter, retrospective registry to collect 9-12 month follow-up data to evaluate major adverse cardiac events in patients whom have undergone percutaneous coronary intervention and received either Taxus Liberte or Xience V.
What is the current status of trial NCT01134159?
This trial is currently completed. The enrollment target is 1,200 participants. The study started on 2010-06. Estimated completion is 2010-09.
Who is sponsoring clinical trial NCT01134159?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia